P E Account Manager
Resume:
***********@*******.***
Seattle, WA
https://www.linkedin.com/i
n/curtis-fowler-30003727/
P E R F O R M A N C E &
A W A R D S
Calliditas Therapeutics
Ranked top third nationally in
Tarpeyo launch (2022)
Bayer Pharmaceuticals
#1 rank regionally in Kerendia
launch (2021)
Mallinckrodt Pharmaceuticals
Exceeded sales goals every year
(2011 – 2020)
Senior Specialist Distinction
(2017)
National Sales Advisory Board
selection (2016)
“Drive to Growth” Winner (2012)
Genzyme
Summit Club Award (2009)
#3/112 rank nationally (2009)
#1 annual rank in district (2009)
National Capsule Crusader
Award (2005)
P R O F I L E
Accomplished and entrepreneurial sales professional motivated to help patients by partnering with clinicians to find the best solutions. Track record of sales growth through a consultative and collaborative approach. Demonstrated ability to find opportunities to drive business through successful multi-state territory management. P R O F E S S I O N A L E X P E R I E N C E
RARE DISEASE ACCOUNT MANAGER January – November 2022 Eversana/Calliditas Therapeutics
Territory included all Nephrologists in states of Washington, Alaska, and Montana.
Launched Tarpeyo, a rare orphan disease medication to treat patients with IGA Nephropathy.
Led account collaboration with Medical Sales Liaison, Reimbursement Manager, and regional team to educate Nephrologists about this first and only FDA approved treatment product.
CARDIO RENAL SALES SPECIALIST May 2021 – January 2022 Bayer Pharmaceuticals
Territory included all Nephrologists in the states of Washington and Alaska.
Launched Kerendia, a treatment to slow the progression of CKD in adults with T2D.
Responsibilities included strong KOL development and partnership with my KOLs in my geography.
SENIOR SALES SPECIALIST July 2011 – August 2020
Nephrology Autoimmune and Rare Diseases
Mallinckrodt Pharmaceuticals (formerly Questcor)
Territory included all Nephrologists in the states of Washington, Oregon, Alaska, Idaho, and Montana.
Consistently exceeded sales expectations annually during entire nine-year employment – promoted to Senior Specialist.
Launched and marketed Acthar, an injectable orphan medication to help reduce protein in Nephrotic Syndrome.
Established strong KOL network and cultivated key partnerships to represent HP Acthar Gel to nephrologists, transplant surgeons and hospitals.
Collaborated with Reimbursement Managers to aid in pull though with managed care groups and specialty pharmacies.
C U R T I S F OWLER
S P E C I A L T Y A C C O U N T M A N A G E R
P R O F E S S I O N A L E X P E R I E N C E c o n t i n u e d CLINICAL SCIENCE SPECIALIST July 2004 – November 2010 Genzyme, Inc
Territory included all Nephrologists and Dialysis Centers in the Eastern Washington and Seattle/North territories.
Launched and marketed Renvela, Hectorol IV and oral Hectorol, a phosphate binder for CKD and dialysis patients.
Represented products to national and independent dialysis units as well as Nephrologists and the Renal medical community.
Focused education efforts beyond doctors to nurses, dieticians, social workers and patients, expanding awareness of benefits of therapies.
Converted 5 dialysis units to Hectorol IV.
MEDICAL SALES REPRESENTATIVE October 2003 – July 2004 MedPointe Pharmaceuticals
Territory included Seattle and southern Washington.
Launched and marketed migraine and allergy medications for start-up, targeting Neurologists and Ophthalmologists.
PROFESSIONAL SALES REPRESENTATIVE December 2002 – September 2003 TAP Pharmaceuticals
Marketed Prevacid to Gastroenterologists, Primary Care Physicians and hospitals in the Seattle Washington territory.
Ranked Top 5% nationally for sales, achieving largest overall total prescription (TRX) and new prescription (NRX) growth.
Negotiated contracts and pricing with Swedish pharmacy manager, expanding sales of hospital system.
SALES REPRESENTATIVE III September 1998 – November 2002 Organon Pharmaceuticals, Inc
Territory included marketing, educating, and introducing new women’s healthcare products to OBGYNs including contraceptive and fertility pharmaceuticals in Seattle, Tacoma, Olympia and eastern Washington.
Ranked in the top 7% nationally for sales of NuvaRing during launch.
Created pre-launch activities for novel contraceptive device, NuvaRing, exceeding required trial registration 400% and gaining immediate success with prescriptions upon official launch.
Identified Madigan Army Medical Center as high potential target and implemented plan to gain support from key leaders, achieving formulary acceptance and generating over $300,000 in revenue.
Grew sales 30% earning Above the Line Award.
Drove sales through strong relationships in rural Eastern Washington, growing niche market 3%.
L E ADERSHIP
S K I L L S
HUB Coordination
Strategic Planner
Tactical Launch Expert
Clinical Expert
Nephrology KOL Developer
Account Management
E D U C A T I O N
Bachelor of Science
Communications
Arizona State University
Tempe, AZ
R E F E R E N C E S
Dr Andrzej Maciejewski
Nephologist
Anchorage, Alaska
cell 907-***-****
Partnered with Dr. Maciejewski in
nephrology and rare disease.
Brian Blankenship
Mallinckrodt – Rare Disease
past team member
cell 901-***-****
Shannon McDaniel
Genzyme – past team member
cell 859-***-****
C U R T I S F O W L E R
Contact this candidate